MartÃn-Sabroso, C.; Alonso-González, M.; Fernández-Carballido, A.; Aparicio-Blanco, J.; Córdoba-DÃaz, D.; Navarro-GarcÃa, F.; Córdoba-DÃaz, M.; Torres-Suárez, A.I.
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations. Pharmaceuticals 2022, 15, 2.
https://doi.org/10.3390/ph15010002
AMA Style
MartÃn-Sabroso C, Alonso-González M, Fernández-Carballido A, Aparicio-Blanco J, Córdoba-DÃaz D, Navarro-GarcÃa F, Córdoba-DÃaz M, Torres-Suárez AI.
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations. Pharmaceuticals. 2022; 15(1):2.
https://doi.org/10.3390/ph15010002
Chicago/Turabian Style
MartÃn-Sabroso, Cristina, Mario Alonso-González, Ana Fernández-Carballido, Juan Aparicio-Blanco, Damián Córdoba-DÃaz, Federico Navarro-GarcÃa, Manuel Córdoba-DÃaz, and Ana I. Torres-Suárez.
2022. "Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations" Pharmaceuticals 15, no. 1: 2.
https://doi.org/10.3390/ph15010002
APA Style
MartÃn-Sabroso, C., Alonso-González, M., Fernández-Carballido, A., Aparicio-Blanco, J., Córdoba-DÃaz, D., Navarro-GarcÃa, F., Córdoba-DÃaz, M., & Torres-Suárez, A. I.
(2022). Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations. Pharmaceuticals, 15(1), 2.
https://doi.org/10.3390/ph15010002